InvestSMART

Nanoveu Limited (ASX: NVU) - Announcements

Current share price for NVU : $0.069 0.003 (4.17%)+

ASX company news and announcements for Nanoveu Limited (NVU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nanoveu Limited (NVU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nanoveu Limited (NVU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nanoveu Limited (NVU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$75 Preliminary Final Report 1 Mar 2022 8:56AM $0.027 $0.069 risen by 155.56%
$75 Nanoveu Launches Spray Coating Effective Against MHV-A59 9 Feb 2022 9:55AM $0.030 $0.069 risen by 130%
$75 Notification regarding unquoted securities - NVU 2 Feb 2022 5:42PM $0.031 $0.069 risen by 122.58%
$75 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2022 4:09PM $0.030 $0.069 risen by 130%
$75 Notice under Section 708A(5)(e) of the Corporations Act 2001 12 Jan 2022 4:13PM $0.028 $0.069 risen by 146.43%
$75 Application for quotation of securities - NVU 12 Jan 2022 4:08PM $0.028 $0.069 risen by 146.43%
$75 Change of Director's Interest Notice x 4 5 Jan 2022 4:11PM $0.032 $0.069 risen by 115.63%
$75 Notification of cessation of securities - NVU 5 Jan 2022 4:10PM $0.032 $0.069 risen by 115.63%
$75 Change of Registry Address 20 Dec 2021 2:56PM $0.032 $0.069 risen by 115.63%
$75 Notification of cessation of securities - NVU 30 Nov 2021 5:48PM $0.036 $0.069 risen by 91.67%
$75 Third Share Subscription 23 Nov 2021 4:07PM $0.040 $0.069 risen by 72.50%
$75 Nanoveu Receives Patent Approval for EyeFyx 18 Nov 2021 5:15PM $0.038 $0.069 risen by 81.58%
$75 Broker Briefing Investor Webinar Presentation 18 Nov 2021 11:47AM $0.041 $0.069 risen by 68.29%
$75 Additional Information to the Sep 2021 Quarterly Report 16 Nov 2021 4:13PM $0.040 $0.069 risen by 72.50%
$75 Notification of cessation of securities - NVU 16 Nov 2021 4:13PM $0.040 $0.069 risen by 72.50%
$75 Broker Briefing Investor Webinar 15 Nov 2021 4:53PM $0.040 $0.069 risen by 72.50%
$75 Notice under Section 708A(5)(e) of the Corporations Act 2001 12 Nov 2021 6:50PM $0.040 $0.069 risen by 72.50%
$75 Application for quotation of securities - NVU 12 Nov 2021 6:47PM $0.040 $0.069 risen by 72.50%
$75 Update on Performance Rights 11 Nov 2021 7:49PM $0.037 $0.069 risen by 86.49%
$75 Application for quotation of securities - NVU 11 Nov 2021 6:56PM $0.037 $0.069 risen by 86.49%
$75 Investor Webinar Presentation 10 Nov 2021 12:55PM $0.039 $0.069 risen by 76.92%
$75 Investor Webinar 9 Nov 2021 4:23PM $0.042 $0.069 risen by 64.29%
$75 Strategic License and Supply Agreement with Cupron, Inc. 9 Nov 2021 9:29AM $0.043 $0.069 risen by 60.47%
$75 Results of Meeting 8 Nov 2021 4:37PM $0.043 $0.069 risen by 60.47%
$75 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2021 6:34PM $0.037 $0.069 risen by 86.49%

426 - 450 of 652 results

Page 18 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.